BrainsWay Ltd (BRSYF) Stock Price, Trades & News

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Financial Strength

9/10

Name	Current	Vs Industry
Cash-To-Debt	8.91
Equity-to-Asset	0.65
Debt-to-Equity	0.09
Debt-to-EBITDA	0.53
Interest Coverage	2.73
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	9.58	Distress Grey Safe
Beneish M-Score	-0.34	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

8/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	17
	3-Year Book Growth Rate	10.8
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	37.63
	Future 3-5Y Total Revenue Growth Rate Estimate	22.07

Momentum Rank

6/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	100
	9-Day RSI	100
	14-Day RSI	100
	6-1 Month Momentum %	55.21
	12-1 Month Momentum %	298.53

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	3.34
	Quick Ratio	3.04
	Cash Ratio	2.54
	Days Inventory	142.56
	Days Sales Outstanding	35.83
	Days Payable	60.76

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-5.8
	Shareholder Yield %	-0.16

Profitability Rank

3/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	75.51
	Operating Margin %	10.23
	Net Margin %	15.68
	EBITDA Margin %	22.36
	FCF Margin %	21.55
	OCF Margin %	25.22
	ROE %	12.56
	ROA %	7.94
	ROIC %	13.69
	3-Year ROIIC %	52.13
	ROC (Joel Greenblatt) %	84.16
	ROCE %	12.44
	Years of Profitability over Past 10-Year	2
	Moat Score	6
	Tariff Resilience Score	6

GF Value Rank

3/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	72.12
	Forward PE Ratio	61.59
	PE Ratio without NRI	72.12
	Price-to-Owner-Earnings	53.91
	PS Ratio	11.25
	PB Ratio	8.39
	Price-to-Tangible-Book	8.36
	Price-to-Free-Cash-Flow	52.71
	Price-to-Operating-Cash-Flow	44.91
	EV-to-EBIT	53.16
	EV-to-EBITDA	46.35
	EV-to-Revenue	10.36
	EV-to-Forward-Revenue	8.41
	EV-to-FCF	48.24
	Price-to-GF-Value	2.16
	Price-to-Projected-FCF	8.47
	Price-to-Median-PS-Value	2.25
	Price-to-Graham-Number	5.19
	Price-to-Net-Current-Asset-Value	16.94
	Price-to-Net-Cash	33.88
	Earnings Yield (Greenblatt) %	1.88
	FCF Yield %	1.91

Financials (Next Earnings Date:2026-08-13 Est.)

Annual Quarterly TTM

BRSYF's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with OTCPK:BRSYF

No Available Data

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

BrainsWay Ltd Executives

Details

GF Value™: $6.27

BRSYF

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 2 Severe warning signs with BRSYF. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil $)	56.22
	EPS (TTM) ($)	0.22
	Beta	-1.5169
	3-Year Sharpe Ratio	1.4
	3-Year Sortino Ratio	4.59
	Volatility %	74.87
	14-Day RSI	100
	14-Day ATR ($)	0.00146
	20-Day SMA ($)	13.55
	12-1 Month Momentum %	298.53
	52-Week Range ($)	3.4 - 13.55
	Shares Outstanding (Mil)	40.13

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

BrainsWay Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

BrainsWay Ltd Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings conference call for 2026	2026-11-11 08:30	In 127 days
Third quarter earnings results for 2026	2026-11-11	In 126 days
Second quarter earnings conference call for 2026	2026-08-13 08:30	In 37 days
Second quarter earnings results for 2026	2026-08-13	In 36 days
First quarter earnings conference call for 2026	2026-05-13 08:30	13.55 (+0.00%)
First quarter earnings results for 2026	2026-05-13	13.55 (+0.00%)
Annual report for 2025	2026-04-20	13.55 (+0.00%)
25(th) Annual Needham Virtual Healthcare Conference	2026-04-15 08:45	13.55 (+0.00%)
Fourth quarter earnings conference call for 2025	2026-03-11 08:30	11.87 (+0.00%)
Fourth quarter earnings results for 2025	2026-03-11	11.87 (+0.00%)

Show

Entries

BrainsWay Ltd Frequently Asked Questions

What is BrainsWay Ltd(BRSYF)'s stock price today?

The current price of BRSYF is $13.55. The 52 week high of BRSYF is $13.55 and 52 week low is $3.40.

When is next earnings date of BrainsWay Ltd(BRSYF)?

The next earnings date of BrainsWay Ltd(BRSYF) is 2026-08-13 Est..

Does BrainsWay Ltd(BRSYF) pay dividends? If so, how much?

BrainsWay Ltd(BRSYF) does not pay dividend.

Guru Commentaries on OTCPK:BRSYF

No articles.

Press Release

	Subject	Date
	Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay	2025-08-21
	Thinking about buying stock in Brainsway, Microvision, Recursion Pharmaceuticals, Dave & Buster's Entertainment, or Grid Dynamics?	2023-06-07
	Carolina Partners in Mental HealthCare Expands Treatment Offerings to Include Revolutionary Mental Health Technology for Obsessive-Compulsive Disorder in North Carolina	2019-05-13

10/Page

Articles on BrainsWay Ltd

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.